Literature DB >> 14667194

Prevention of life-threatening infections due to encapsulated bacteria in children with hyposplenia or asplenia: a brief review of current recommendations for practical purposes.

Elio Castagnola1, Francesca Fioredda.   

Abstract

The aim of the present work was to summarise in a single paper all the options for prevention of life-threatening infections due to encapsulated bacteria in patients with hyposplenism or asplenia. Prevention of these infections should be obtained in all patients with 1) patient and family education, 2) prophylaxis by means of vaccination against Haemophilus influenzae and Streptococcus pneumoniae, 3) antibiotic prophylaxis, based primarily on penicillin, 4) delay of elective splenectomy or use methods of tissue salvage in splenic trauma. Vaccination is not effective against all serotypes of S. pneumoniae and Neisseria meningitidis causing life-threatening infections in hypo/asplenic patients. Moreover, antibacterial prophylaxis could select antibacterial-resistant pathogens and is highly conditioned by patient's compliance. Therefore, empirical antibacterial therapy of fever and/or suspected infection should be recommended to all splenectomised patients independently from time elapsing from splenectomy, vaccinal status and assumption of antibacterial prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667194     DOI: 10.1034/j.1600-0609.2003.00158.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  22 in total

Review 1.  Hematologic manifestations of celiac disease.

Authors:  Thorvardur R Halfdanarson; Mark R Litzow; Joseph A Murray
Journal:  Blood       Date:  2006-09-14       Impact factor: 22.113

2.  Vanishing spleen after Nissen fundoplication: a case report.

Authors:  Koen P Dijkman; L W Ernest van Heurn; Piet L J M Leroy; Gijs D Vos
Journal:  Eur J Pediatr       Date:  2008-07-03       Impact factor: 3.183

Review 3.  The splenic marginal zone in humans and rodents: an enigmatic compartment and its inhabitants.

Authors:  Birte Steiniger; Eva Maria Timphus; Peter J Barth
Journal:  Histochem Cell Biol       Date:  2006-07-01       Impact factor: 4.304

4.  Clinical spectrum of serious bacterial infections among splenectomized patients with hemoglobinopathies in Israel: a 37-year follow-up study.

Authors:  W Sakran; C Levin; Y Kenes; R Colodner; A Koren
Journal:  Infection       Date:  2011-08-25       Impact factor: 3.553

Review 5.  Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.

Authors:  Arturo J Martí-Carvajal; Lucieni O Conterno
Journal:  Cochrane Database Syst Rev       Date:  2016-11-14

Review 6.  Apoptotic cell responses in the splenic marginal zone: a paradigm for immunologic reactions to apoptotic antigens with implications for autoimmunity.

Authors:  Tracy L McGaha; Mikael C I Karlsson
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

Review 7.  Is it worth investigating splenic function in patients with celiac disease?

Authors:  Antonio Di Sabatino; Laura Brunetti; Gabriella Carnevale Maffè; Paolo Giuffrida; Gino Roberto Corazza
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

8.  Immune response to the 7-valent pneumococcal conjugate vaccine in 30 asplenic children.

Authors:  B Mikoluc; H Kayhty; E Bernatowska; R Motkowski
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-27       Impact factor: 3.267

Review 9.  Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes.

Authors:  Andrea Cerutti; Montserrat Cols; Irene Puga
Journal:  Nat Rev Immunol       Date:  2013-02       Impact factor: 53.106

Review 10.  Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease.

Authors:  Dan M Granoff
Journal:  Vaccine       Date:  2009-05-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.